Authors' recommendations: Uveitis is an inflammation that affects the lining of the eye. It can lead to eye pain, eye redness, headaches, and problems with vision that can become permanent. It may be caused by an infection, but in many cases the cause of uveitis is unknown. Medidur is a new drug implant that is injected straight into the back of the eye. It releases a corticosteroid drug called fluocinolone acetonide for as long as 3 years. Corticosteroids are already used to treat uveitis, but need to be taken daily as tablets or injected into the eye on regular occasions. If Medidur is licensed for use in the UK, it could be a new treatment option for patients with uveitis. It could be particularly helpful for patients who are not responding to standard drug treatments and to try to reduce the risk of the disease returning.

Project Status: Completed

Year Published: 2016

URL for published report: http://www.hsric.nihr.ac.uk/topics/medidur-for-non-infectious-posterior-uveitis-second-line/

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: England, United Kingdom

Organisation Name: NIHR Horizon Scanning Centre

Contact Address: The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269

Contact Name: c.packer@bham.ac.uk

Contact Email: c.packer@bham.ac.uk

Copyright: NIHR Horizon Scanning Research&Intelligence Centre (NIHR HSRIC)